ABVC BioPharma, Inc. (ABVC) vs aTyr Pharma, Inc. (ATYR)
A side-by-side comparison of ABVC BioPharma, Inc. and aTyr Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ABVC vs ATYR
growth of $100 · dividends reinvested · last 2yABVC +14.5% (+7.0%/yr)ATYR -83.2% (-59.1%/yr)ABVC compounded faster over this window
Log scale — wide-divergence pair
ABVC ATYR
ABVC vs ATYR: by the numbers
- •ATYR is the larger company ($29M vs $25M market cap).
- •Both run net losses; ABVC's is the smaller (0.00% vs -32003.68% net margin).
Metrics side by side
Valuation
| Metric | ABVC | ATYR |
|---|---|---|
| P/S ratio | N/A | 151.05 |
| P/B ratio | 2.44 | 0.59 |
Profitability
| Metric | ABVC | ATYR |
|---|---|---|
| Gross margin | 0.00% | -717.37% |
| Operating margin | 0.00% | -40856.32% |
| Net margin | 0.00% | -32003.68% |
| ROE | -76.82% | -124.64% |
| ROIC | -53.34% | -109.29% |
Growth (annualized)
| Metric | ABVC | ATYR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -38.74% |
| Total return CAGR (5Y) | -46.33% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.